Last update 15 Feb 2025

Semaglutide(Merdury Biopharmaceutical Corporation)

Overview

Basic Info

Drug Type
Recombinant polypeptide
Synonyms-
Target
GLP-1R
Mechanism
GLP-1R modulators(Glucagon-like peptide 1 receptor modulators)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes MellitusObesity
Inactive Indication-
Originator Organization
Merdury Biopharmaceutical Corporation
Active Organization
Merdury Biopharmaceutical Corporation
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

5
Clinical Trials associated with Semaglutide(Merdury Biopharmaceutical Corporation)
ChiCTR2500096141
/ SuspendedNot ApplicableIIT
The effect of semaglutide injection on gastric emptying time
ChiCTR2500096405
/ SuspendedPhase 4IIT
A single-center, randomized, placebo-controlled, double-blind study: the efficacy and safety of WONDERLAB SHAPE100TM oral probiotics in combination with once-weekly subcutaneous injections of semaglutide in obese people
JPRN-UMIN000051846
/ CompletedNot ApplicableIIT
Investigation of factors that predict efficacy when switching from DPP-4 inhibitors to oral semaglutide - Investigation of factors that predict efficacy when switching from DPP-4 inhibitors to oral semaglutide
100 Clinical Results associated with Semaglutide(Merdury Biopharmaceutical Corporation)
Login to view more data
100 Translational Medicine associated with Semaglutide(Merdury Biopharmaceutical Corporation)
Login to view more data
100 Patents (Medical) associated with Semaglutide(Merdury Biopharmaceutical Corporation)
Login to view more data
100 Deals associated with Semaglutide(Merdury Biopharmaceutical Corporation)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes MellitusPreclinical
CN
Merdury Biopharmaceutical Corporation
25 Jul 2024
ObesityPreclinical
CN
Merdury Biopharmaceutical Corporation
25 Jul 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free